JP2024516605A5 - - Google Patents
Info
- Publication number
- JP2024516605A5 JP2024516605A5 JP2023564191A JP2023564191A JP2024516605A5 JP 2024516605 A5 JP2024516605 A5 JP 2024516605A5 JP 2023564191 A JP2023564191 A JP 2023564191A JP 2023564191 A JP2023564191 A JP 2023564191A JP 2024516605 A5 JP2024516605 A5 JP 2024516605A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- absent
- formula
- protein molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021901169 | 2021-04-20 | ||
| AU2021901169A AU2021901169A0 (en) | 2021-04-20 | Novel compositions and methods for treating coronavirus infections | |
| AU2022900358A AU2022900358A0 (en) | 2022-02-18 | Novel compositions and methods for treating coronavirus infections | |
| AU2022900358 | 2022-02-18 | ||
| PCT/AU2022/050363 WO2022221920A1 (en) | 2021-04-20 | 2022-04-20 | Novel compositions and methods for treating coronavirus infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516605A JP2024516605A (ja) | 2024-04-16 |
| JP2024516605A5 true JP2024516605A5 (https=) | 2025-08-06 |
Family
ID=83723477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564191A Pending JP2024516605A (ja) | 2021-04-20 | 2022-04-20 | コロナウイルス感染を処置するための新規組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240352072A1 (https=) |
| EP (1) | EP4326757A4 (https=) |
| JP (1) | JP2024516605A (https=) |
| KR (1) | KR20240027579A (https=) |
| AU (1) | AU2022260860A1 (https=) |
| CA (1) | CA3216329A1 (https=) |
| IL (1) | IL307872A (https=) |
| WO (1) | WO2022221920A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024020646A1 (en) * | 2022-07-27 | 2024-02-01 | The Council Of The Queensland Institute Of Medical Research | Methylation biomarker for infection resistance |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6989363B1 (en) * | 1997-12-11 | 2006-01-24 | Millennium Pharmaceuticals, Inc. | Angiotensin converting enzyme homolog and therapeutic and diagnostic uses therefor |
| WO2002012471A2 (en) * | 2000-08-09 | 2002-02-14 | Millennium Pharmaceuticals, Inc. | Angiotensin converting enzyme homolog and uses therefor |
| WO2007030937A2 (en) * | 2005-09-16 | 2007-03-22 | Institut De Recherches Cliniques De Montreal/I.R.C.M. | Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors |
| CA2652247C (en) * | 2006-05-08 | 2015-11-17 | Adaerata, Limited Partnership | Chimeric pcsk9 proteins, cells comprising same, and assays using same |
| US20230152316A1 (en) * | 2020-03-19 | 2023-05-18 | Massachusetts Institute Of Technology | Sars-cov2 spike protein binding peptides |
| WO2021195723A1 (en) * | 2020-04-03 | 2021-10-07 | The Council Of The Queensland Institute Of Medical Research | "methods for treatment of coronavirus infections" |
| CA3179872A1 (en) * | 2020-04-22 | 2021-10-28 | Dana-Farber Cancer Institute, Inc. | Antiviral structurally-stabilized ace2 helix 1 peptides and uses thereof |
| CN111920806B (zh) * | 2020-07-14 | 2023-01-03 | 中日友好医院(中日友好临床医学研究所) | 苹果酸舒尼替尼在制备抑制冠状病毒的药物中的应用 |
| WO2022075921A1 (en) * | 2020-10-08 | 2022-04-14 | Hummingbird Bioscience Holdings Limited | Sars-cov-2 spike protein antigen-binding molecules |
-
2022
- 2022-04-20 JP JP2023564191A patent/JP2024516605A/ja active Pending
- 2022-04-20 WO PCT/AU2022/050363 patent/WO2022221920A1/en not_active Ceased
- 2022-04-20 AU AU2022260860A patent/AU2022260860A1/en active Pending
- 2022-04-20 EP EP22790610.4A patent/EP4326757A4/en active Pending
- 2022-04-20 IL IL307872A patent/IL307872A/en unknown
- 2022-04-20 KR KR1020237039897A patent/KR20240027579A/ko active Pending
- 2022-04-20 CA CA3216329A patent/CA3216329A1/en active Pending
- 2022-04-20 US US18/287,793 patent/US20240352072A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8785375B2 (en) | Cyclic antimicrobial peptides for treating bacterial infections | |
| CN109641034A (zh) | 聚乙二醇化的猪干扰素及其使用方法 | |
| JP5002603B2 (ja) | 新規なペプチド及びこれの用途 | |
| US9518093B2 (en) | Topical formulation of arginine-rich cyclic antimicrobial peptides | |
| JP2010090162A (ja) | 人ラクトフェリンの配列に基づくペプチドおよびその使用 | |
| CN111704653B (zh) | 靶向于纤连蛋白衍生肽的抑制剂多肽化合物及其用途 | |
| DK165988B (da) | Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c | |
| EP0401109A1 (fr) | Microprotéines, procédé de préparation et application à titre de médicaments de ces microprotéines | |
| JP3312946B2 (ja) | ウイルス感染・増殖抑制剤 | |
| JP2024516605A5 (https=) | ||
| CN112891512B (zh) | 多肽化合物在预防或治疗肝纤维化中的应用 | |
| US11278514B2 (en) | Composition compromising dunnione as effective ingredient for prevention or alleviation of hair loss | |
| JPH04266899A (ja) | ヒトリポコルチンから誘導される合成ペプチド及びその用途 | |
| JP2015160827A (ja) | 急性腎障害に起因する多臓器不全の予防又は治療薬 | |
| JP3770624B2 (ja) | ウィルス感染・増殖抑制剤 | |
| JP2012504941A5 (https=) | ||
| JP7046990B2 (ja) | 医薬的特性が改善されたプロドラッグペプチド | |
| BRPI0619641A2 (pt) | peptìdeo cìclico ou variante do mesmo, processo para a preparação de um peptìdeo, peptìdeo ciclizado, composição, uso de um peptìdeo cìclico ou variante do mesmo, e, método para tratar ou previnir uma infecção microbiana em um indivìduo | |
| JP4188897B2 (ja) | ウィルス感染・増殖抑制剤 | |
| JP3190765B2 (ja) | ペプチド誘導体及びその用途 | |
| RU2008125167A (ru) | Терапевтическое средство для ускоренного заживления кожи, содержащее в качестве активного ингредиента дезацил-грелин и его производные | |
| JPH03123490A (ja) | 新規なセリンプロテアーゼインヒビター蛋白質、これを含む医薬、この蛋白質のためにコードするｄｎａ配列及びこれら蛋白質、医薬及びｄｎａ配列を作り出す方法 | |
| JPH08157492A (ja) | 抗動脈硬化ペプチド | |
| CN107970433A (zh) | 钙敏感受体相关肽类的药物组合物及其应用 | |
| FR2717391A1 (fr) | Peptides pour inhiber la libération de pepsine. |